Advance Directives Completion Rates and an Intervention to Address Health Literacy in a Clinic Population
NCT ID: NCT02702284
Last Updated: 2018-11-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
529 participants
INTERVENTIONAL
2017-06-05
2018-11-15
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The aim of this research study is to enhance completion rates of advance directives by taking into consideration a patient's health literacy level. Specifically, the investigators plan to assess the impact of an ambulatory intervention on the completion rate of advance directives for patients with adequate and limited health literacy. The hypothesis is that both groups (adequate and limited health literacy) will benefit from the intervention, but patients with limited health literacy will show a greater improvement in the advance directives completion rate.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Comparison of an Easy to Read Advance Directive Versus a Standard Advance Directive
NCT00328055
Patient Understanding of End of Life Care
NCT01683097
Health Literacy Assessment and Intervention to Reduce Disparities: FLIGHT/VIDAS II
NCT02922439
Evaluating a Low-Literacy Discharge Medication Education Tool
NCT00408733
Impact of Active Choice on Advance Directive Completion Rates
NCT02289105
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
At the time of the clinic visit to the Internal Medicine at Medical Plaza (IMMP) or the Internal Medicine at Tower Hill (IMTH) subjects will be invited to participate in the study.
Research Assistant(s) RA Responsibilities:
All Potential Study Subjects:
1. RA will interview study subject in a private area (exam room or empty office).
2. RA will assess eligibility criteria.
3. RA will obtain informed consent.
4. RA will randomize the subjects to either intervention or control.
5. RA will explain to the subjects how to return the advance directive (AD)
For the Intervention group:
1. RA will review and walk through the University of Florida (UF) AD brochure
2. RA will offer subjects a link to a patient education video on advance directives. The link will be texted or emailed or given in paper per the subject's preference.
3. RA will conduct a brief satisfaction questionnaire addressing the activity review of the UF AD brochure.
4. RA will ask
1. Did addressing advance directives enhance today's experience at the clinic?
2. Do you think that advance directives be routinely addressed at visits to the doctor?
Control group:
If the subject is ready to complete an advance directive they will be referred to clinic staff for assistance.
RA will ask
1. Did addressing advance directives enhance today's experience at the clinic?
2. Do you think that advance directives should be routinely addressed at visits to the doctor?
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Adequate health literacy, control
This group of subjects will be referred to clinic staff for assistance with the advance directives (AD) and will not receive assistance from a research assistant. In addition, the research assistance will ask questions regarding the information received for the AD.
Advance Directives without assistance
This group of subjects will be provided with the advance directive and then referred to clinic staff for assistance.
Adequate health literacy, intervention
The subjects in this group will hear a research assistant review the advance directive and be offered an opportunity to watch a video about advance directives.
Advance Directives
These subject's will have a research assistant (RA) review and walk through the advance directives brochure. The RA will read all of the brochure to the patient and prompt for questions. In addition, a link to an educational video on advance directives. The advance directive link will be either texted or emailed or given in paper per the subject's preference.
Limited health literacy, control
This group of subjects will be referred to clinic staff for assistance with the advance directives (AD) and will not receive assistance from a research assistant. In addition, the research assistance will ask questions regarding the information received for the AD.
Advance Directives without assistance
This group of subjects will be provided with the advance directive and then referred to clinic staff for assistance.
Limited health literacy, intervention
The subjects in this group will hear a research assistant review the advance directive and be offered an opportunity to watch a video about advance directives.
Advance Directives
These subject's will have a research assistant (RA) review and walk through the advance directives brochure. The RA will read all of the brochure to the patient and prompt for questions. In addition, a link to an educational video on advance directives. The advance directive link will be either texted or emailed or given in paper per the subject's preference.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Advance Directives
These subject's will have a research assistant (RA) review and walk through the advance directives brochure. The RA will read all of the brochure to the patient and prompt for questions. In addition, a link to an educational video on advance directives. The advance directive link will be either texted or emailed or given in paper per the subject's preference.
Advance Directives without assistance
This group of subjects will be provided with the advance directive and then referred to clinic staff for assistance.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* speaks English,
* has intact cognitive function
Exclusion Criteria
* already has an advance directive in electronic medical record,
* does not speak English,
* cognitive dysfunction
51 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Florida
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Melanie G Hagen, MD
Role: PRINCIPAL_INVESTIGATOR
University of Florida
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Tower Hill Internal Medicine
Gainesville, Florida, United States
Internal Medicine at Medical Plaza
Gainesville, Florida, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Barker PC, Holland NP, Shore O, Cook RL, Zhang Y, Warring CD, Hagen MG. The Effect of Health Literacy on a Brief Intervention to Improve Advance Directive Completion: A Randomized Controlled Study. J Prim Care Community Health. 2021 Jan-Dec;12:21501327211000221. doi: 10.1177/21501327211000221.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
IRB201500776
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.